(Q33479695)

English

A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

phase II clinical trial

0 references

author name string

A Martoni

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

M Giovannini

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

L Tomasi

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C M Camaggi

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

B Bellanova

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

N Monetti

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

G Rossini

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

M Tarquinii

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A Martini

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

F Pannuti

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

179-182

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

https://scigraph.springernature.com/pub.10.1007/bf00256541

0 references

Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4'-epi-doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary phase I study of 4'-epi-adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase of I trial of 4'-epi-Adriamycin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QRS voltage change with adriamycin administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/6584236

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00256541

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33479695&oldid=1988058174"